Company Information

Headquarters
United States
Founded in
2012
Employees
Speciality
biotechnologyimmunotherapycell therapygene therapyT-cellsCTLsallogeneicoff the shelfcanceroncologyimmuno-oncologyhematologyimmunologyautoimmune diseasesmultiple sclerosisMSEpstein-Barr virusEBVPTLDCytomegalovirusCMVoncovirusesstem cell transplantlymphomasecondary lymphomasecondary malignancyEBV lymphomaAtara BioAtaraATRACAR Tsolid tumors
Overview
Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune disease. With our lead program in Phase 3 clinical development, Atara is the most advanced allogeneic T-cell immunotherapy company and intends to rapidly deliver off-the-shelf treatments to patients with high unmet medical need. Our platform leverages the unique biology of EBV T cells and has the capability to treat a wide range of EBV-associated diseases, or other serious diseases through incorporation of engineered CARs (chimeric antigen receptors) or TCRs (T-cell receptors). Atara is applying this one platform to create a robust pipeline including: tab-cel® (tabelecleucel) in Phase 3 development for Epstein-Barr virus-driven post-transplant lymphoproliferative disease (EBV+ PTLD); ATA188, a T-cell immunotherapy targeting EBV antigens as a potential treatment for multiple sclerosis; and multiple next-generation chimeric antigen receptor T-cell (CAR-T) immunotherapies for both solid tumors and hematologic malignancies. Improving patients’ lives is our mission and we will never stop working to bring transformative therapies to those in need. Atara is headquartered in South San Francisco and our leading-edge research, development and manufacturing facility is based in Thousand Oaks, California. Working at Atara People at Atara are high integrity, collaborative, roll-up-your-sleeves types who are deeply committed to putting patients first and advancing medical care with demonstrated urgency. With many accomplished people at Atara, we share humility, flexibility, respect, teamwork, good judgment and being practical in our approach to advance our therapies. We each enjoy in the journey of advancing cutting edge programs, while responsibly teaching and learning together along the way.
search

Sign Up to View Atara Biotherapeutics’s Top Employees

Instant access. Cancel anytime

Start with AroundDeal For Free!

Use AroundDeal to build prospect lists in 1 click.

Instant access. Cancel anytime

Get Contact Info for All Employees

Employees:

static-employee
Shailender Gunnala

Vice President | Head of IT

static-employee
Marianna Arutyunyan

Quality Control Specialist

static-employee
Hyonelle Im Youngson

Vice President, Cultural Transformation and Chief of Staff to CEO at Atara Biotherapeutics


static-employee
Linda Mach

Warehouse Operations and Clinical Distribution Senior Manager

static-employee
Ruth E. Holcomb

Clinical Trial Specialist